These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 21937640)

  • 1. Hepatitis C virus-induced cancer stem cell-like signatures in cell culture and murine tumor xenografts.
    Ali N; Allam H; May R; Sureban SM; Bronze MS; Bader T; Umar S; Anant S; Houchen CW
    J Virol; 2011 Dec; 85(23):12292-303. PubMed ID: 21937640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating tumor and cancer stem cells in hepatitis C virus-associated liver disease.
    Bahnassy AA; Zekri AR; El-Bastawisy A; Fawzy A; Shetta M; Hussein N; Omran D; Ahmed AA; El-Labbody SS
    World J Gastroenterol; 2014 Dec; 20(48):18240-8. PubMed ID: 25561791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of the putative intestinal stem cell marker doublecortin and CaM kinase-like-1 in Barrett's esophagus and esophageal adenocarcinoma.
    Vega KJ; May R; Sureban SM; Lightfoot SA; Qu D; Reed A; Weygant N; Ramanujam R; Souza R; Madhoun M; Whorton J; Anant S; Meltzer SJ; Houchen CW
    J Gastroenterol Hepatol; 2012 Apr; 27(4):773-80. PubMed ID: 21916995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C virus promotes hepatocellular carcinogenesis by targeting TIPE2, a new regulator of DNA damage response.
    Wang Y; Jiang Y; Zhou J; Song W; Li J; Wang M; Chen J; Xu R; Zhang J; Ma F; Chen YH; Ma Y
    Tumour Biol; 2016 Nov; 37(11):15265-15274. PubMed ID: 27696294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocellular carcinoma xenograft supports HCV replication: a mouse model for evaluating antivirals.
    Hazari S; Hefler HJ; Chandra PK; Poat B; Gunduz F; Ooms T; Wu T; Balart LA; Dash S
    World J Gastroenterol; 2011 Jan; 17(3):300-12. PubMed ID: 21253388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promotion of Cancer Stem-Like Cell Properties in Hepatitis C Virus-Infected Hepatocytes.
    Kwon YC; Bose SK; Steele R; Meyer K; Di Bisceglie AM; Ray RB; Ray R
    J Virol; 2015 Nov; 89(22):11549-56. PubMed ID: 26355082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular prognostic profile of Egyptian HCC cases infected with hepatitis C virus.
    Zekri AR; Hassan ZK; Bahnassy AA; Sherif GM; ELdahshan D; Abouelhoda M; Ali A; Hafez MM
    Asian Pac J Cancer Prev; 2012; 13(11):5433-8. PubMed ID: 23317196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transient mTOR inhibition facilitates continuous growth of liver tumors by modulating the maintenance of CD133+ cell populations.
    Yang Z; Zhang L; Ma A; Liu L; Li J; Gu J; Liu Y
    PLoS One; 2011; 6(12):e28405. PubMed ID: 22145042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory and oncogenic roles of a tumor stem cell marker doublecortin-like kinase (DCLK1) in virus-induced chronic liver diseases.
    Ali N; Chandrakesan P; Nguyen CB; Husain S; Gillaspy AF; Huycke M; Berry WL; May R; Qu D; Weygant N; Sureban SM; Bronze MS; Dhanasekaran DN; Houchen CW
    Oncotarget; 2015 Aug; 6(24):20327-44. PubMed ID: 25948779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of Gadd45beta expression by hepatitis C virus leads to defective cell cycle arrest.
    Higgs MR; Lerat H; Pawlotsky JM
    Cancer Res; 2010 Jun; 70(12):4901-11. PubMed ID: 20530689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective blockade of DCAMKL-1 results in tumor growth arrest by a Let-7a MicroRNA-dependent mechanism.
    Sureban SM; May R; Ramalingam S; Subramaniam D; Natarajan G; Anant S; Houchen CW
    Gastroenterology; 2009 Aug; 137(2):649-59, 659.e1-2. PubMed ID: 19445940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Active glycolytic metabolism in CD133(+) hepatocellular cancer stem cells: regulation by MIR-122.
    Song K; Kwon H; Han C; Zhang J; Dash S; Lim K; Wu T
    Oncotarget; 2015 Dec; 6(38):40822-35. PubMed ID: 26506419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DLK1 as a potential target against cancer stem/progenitor cells of hepatocellular carcinoma.
    Xu X; Liu RF; Zhang X; Huang LY; Chen F; Fei QL; Han ZG
    Mol Cancer Ther; 2012 Mar; 11(3):629-38. PubMed ID: 22238367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of human kinases involved in hepatitis C virus replication by small interference RNA library screening.
    Supekova L; Supek F; Lee J; Chen S; Gray N; Pezacki JP; Schlapbach A; Schultz PG
    J Biol Chem; 2008 Jan; 283(1):29-36. PubMed ID: 17951261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of ATOH8 Increases Stem Cell Features of Hepatocellular Carcinoma Cells.
    Song Y; Pan G; Chen L; Ma S; Zeng T; Man Chan TH; Li L; Lian Q; Chow R; Cai X; Li Y; Li Y; Liu M; Li Y; Zhu Y; Wong N; Yuan YF; Pei D; Guan XY
    Gastroenterology; 2015 Oct; 149(4):1068-81.e5. PubMed ID: 26099525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C Virus-Induced Upregulation of MicroRNA miR-146a-5p in Hepatocytes Promotes Viral Infection and Deregulates Metabolic Pathways Associated with Liver Disease Pathogenesis.
    Bandiera S; Pernot S; El Saghire H; Durand SC; Thumann C; Crouchet E; Ye T; Fofana I; Oudot MA; Barths J; Schuster C; Pessaux P; Heim MH; Baumert TF; Zeisel MB
    J Virol; 2016 Jul; 90(14):6387-6400. PubMed ID: 27147737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effects of transcription factor Ikaros on the expression of liver cancer stem cell marker CD133 in hepatocellular carcinoma.
    Zhang L; Li H; Ge C; Li M; Zhao FY; Hou HL; Zhu MX; Tian H; Zhang LX; Chen TY; Jiang GP; Xie HY; Cui Y; Yao M; Li JJ
    Oncotarget; 2014 Nov; 5(21):10621-35. PubMed ID: 25301737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The osteopontin-CD44 axis in hepatic cancer stem cells regulates IFN signaling and HCV replication.
    Shirasaki T; Honda M; Yamashita T; Nio K; Shimakami T; Shimizu R; Nakasyo S; Murai K; Shirasaki N; Okada H; Sakai Y; Sato T; Suzuki T; Yoshioka K; Kaneko S
    Sci Rep; 2018 Sep; 8(1):13143. PubMed ID: 30177680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluvastatin interferes with hepatitis C virus replication via microtubule bundling and a doublecortin-like kinase-mediated mechanism.
    Ali N; Allam H; Bader T; May R; Basalingappa KM; Berry WL; Chandrakesan P; Qu D; Weygant N; Bronze MS; Umar S; Janknecht R; Sureban SM; Huycke M; Houchen CW
    PLoS One; 2013; 8(11):e80304. PubMed ID: 24260365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of novel tumor markers in hepatitis C virus-associated hepatocellular carcinoma.
    Smith MW; Yue ZN; Geiss GK; Sadovnikova NY; Carter VS; Boix L; Lazaro CA; Rosenberg GB; Bumgarner RE; Fausto N; Bruix J; Katze MG
    Cancer Res; 2003 Feb; 63(4):859-64. PubMed ID: 12591738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.